Cytopath Inc

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 01D0641487
Address 1004 First Street North, Suite 200, Alabaster, AL, 35007
City Alabaster
State AL
Zip Code35007
Phone(205) 664-9797

Citation History (2 surveys)

Survey - July 2, 2019

Survey Type: Special

Survey Event ID: C1F911

Deficiency Tags: D5787 D9999

Summary:

Summary Statement of Deficiencies D5787 TEST RECORDS CFR(s): 493.1283(a) The laboratory must maintain an information or record system that includes the following: (a)(1) The positive identification of the specimen. (a)(2) The date and time of specimen receipt into the laboratory. (a)(3) The condition and disposition of specimens that do not meet the laboratory's criteria for specimen acceptability. (a)(4) The records and dates of all specimen testing, including the identity of the personnel who performed the test(s). This STANDARD is not met as evidenced by: Based on the desk review of materials submitted with the laboratory's Allegation of Compliance it was determined that the laboratory failed to maintain the identity of the personnel who performed the search for prior negative cases for 18 of 23 current high grade squamous intraepithelial lesion (HSIL) and malignant cases from June through August 2018. Findings include: 1. The Survey Team reviewed laboratory records titled FIVE YEAR RETRO-REVIEW OF CURRENT HSIL/CA PAP CASES from June through August 2018. The records failed to identify the personnel who performed the search on 18 of 23 current HSIL and malignancies for prior negative cases. Cases include: - COSO-18-5002 - COSO-18-5300 - COSO-18-6076 - COSO- 18-6411 - COSO-18-6464 - COSO-18-6660 - COSO-18-6677 - COSO-18-6783 - COSO-18-6832 - COSO-18-6861 - COSO-18-7053 - COSO-18-7460 - COSO-18- 7486 - COSO-18-7619 - CMWO-18-364 - CMWO-18-599 - CMWO-18-632 - CMWO-18-635 D9999 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 3, 2019

Survey Type: Standard

Survey Event ID: 6VWX11

Deficiency Tags: D5413 D5473

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on a lack of 2018 room temperature/humidity records, a review of the environmental requirements in the Tissue Tek Cryostat Operator's Manual and an interview with the Corporate Laboratory Manager, the surveyor determined the laboratory failed to monitor and document room temperature and humidity within the laboratory each day the cryostat was used for frozen section processing of patient specimen for eleven months in 2018. The findings include: 1. A review of the operational environmental requirements in the Tissue Tek Cryostat Operator's Manual revealed room temperature should be in the range of 15-28 degrees Celsius, and humidity should be 15-85 percent. 2. A review of the laboratory's records revealed room temperature and humidity were monitored in 2017; these records were reviewed during the previous survey. However, when the surveyor requested the 2018 room temperature and humidity records, these parameters were not monitored until mid- December 2018. There were no records for January thru November 2018. 3. During an interview on 1/3/2019 at approximately 3:00 PM, the Corporate Laboratory Manager was asked why the laboratory had not monitored and documented room temperature/humidity records for most of 2018. The Manager explained that after a new corporate group acquired the laboratory in January 2018, use of the Panther was discontinued. Staff had previously monitored room temperature/humidity because it Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- was required for the Panther, however they had not realized the Tissue Tek Cryostat also had operational environmental requirements. Thus the above noted findings were confirmed. . D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on a lack of documentation for the daily slide control quality, and interviews with the Laboratory Director and the Corporate Laboratory Manager, the surveyor determined the laboratory failed to assess and document the slide stain quality each day of patient testing for six out of twelve months in 2018. The findings include: 1. A review of the Histopathology records revealed no documentation of the daily slide stain quality after 1/15/2018. Documentation of the daily slide stain quality control (QC) did not resume until 7/13/2018. 2. During an interview on 1/3/2019 at approximately 3:00 PM, the Laboratory Director and the Corporate Laboratory Manager were asked about the missing months of slide QC. The Laboratory Director explained a new corporate group acquired the laboratory in January 2018, and she had been told the local owning entity would perform the specimen processing and all the QC and Quality Assurance procedures. The Corporate Laboratory Manager then explained there had been a lapse in communication, and she had not been informed of her responsibilities at the newly acquired laboratory until March 2018. 3. As the interview continued on 1/3/2019 at approximately 3:05 PM, the surveyor explained, it is the responsibility of the testing personnel (i.e. the Director or other Pathologists performing the reading) to assess and document the slide QC each day of patient testing. Thus the above noted findings were confirmed. SURVEYOR ID #32558 Licensure and Certification Surveyor -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access